This firm's average rating is Buy from 5 analysts.
We provide advice to complement the regular
expert consensus on Gamida Cell. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time.
The successful prediction of Gamida Cell
stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published
stock prices of traded companies, such as Gamida Cell, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at
the intrinsic value of Gamida Cell based on Gamida Cell hews, social hype, general headline patterns, and widely used
predictive technical indicators. We also calculate exposure to Gamida Cell's
market risk, different
technical and
fundamental indicators, relevant financial multiples and ratios, and then
comparing them to Gamida Cell's related companies.
Watch out for price decline
Please consider monitoring Gamida Cell on a daily basis if you are holding a position in it. Gamida Cell is trading at a penny-stock level, and the possibility of delisting is much higher compared to other delisted stocks. However, just because the stock is trading under one dollar, does not mean it will be marked for deletion.
Most exchanges require public instruments, such as Gamida Cell stock to be traded above the $1 level to remain listed. If Gamida Cell stock price falls below $1 for 30 consecutive trading days, the exchange can delist it. Once the company reaches this point, they will be sent an initial price violation notice directly from an exchange.
Use Technical Analysis to project Gamida expected Price
Gamida Cell technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Gamida Cell technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Gamida Cell trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions.
More Info...Is Gamida Cell valued fairly by the market?
The big decline in price over the last few months for Gamida Cellmay raise some interest from investors. The stock closed today at a share price of
2.42 on slow start in trading volume. The company directors and management failed to add value to investors and positioning the firm supply of money to exploit market volatility in
November. However, diversifying your holdings with Gamida Cell or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.35. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Gamida Cell partners.
| 2018 | 2019 | 2020 | 2021 (projected) |
Current Assets | 62.19 M | 56.7 M | 129.99 M | 104.42 M | Total Assets | 65.16 M | 68.78 M | 155.48 M | 122.77 M |
A growth case for Gamida Cell
Coefficient Of Variation just dropped to -580.77, may suggest upcoming price decrease. Gamida Cell exhibits very low volatility with skewness of 0.58 and kurtosis of 1.14. However, we advise investors to further study Gamida Cell technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Gamida Cell's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Gamida Cell's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
Gamida Cell Implied Volatility
Gamida Cell's implied volatility exposes the market's sentiment of Gamida Cell stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Gamida Cell's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Gamida Cell stock will not fluctuate a lot when Gamida Cell's options are near their expiration.
Our Conclusion on Gamida Cell
Whereas other companies in the biotechnology industry are either recovering or due for a correction, Gamida may not be as strong as the others in terms of longer-term growth potentials. All things considered, as of the 28th of December 2021, our analysis shows that Gamida Cell almost mirrors the market. The company is
undervalued and projects
very high probability of financial unrest for the next 2 years. Our primary 90 days buy vs. sell advice on the company is
Cautious Hold.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Raphi Shpitalnik is a Junior Member of Macroaxis Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time basis at the beginning of the pandemic and eventually acquired a real taste for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Gamida Cell. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com
